글로벌 여성 건강 진단 시장 (2023-2030) : 암, 전염병, 골다공증, 임신 및 출산, 산전

■ 영문 제목 : Women’s Health Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Application(Cancer, Infectious Disease, Osteoporosis, Pregnancy & Fertility, Prenatal), By Region And Segment Forecasts, 2023 - 2030

Grand View Research가 발행한 조사보고서이며, 코드는 GRV23NOV186 입니다.■ 상품코드 : GRV23NOV186
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 9월
■ 페이지수 : 100
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 임상 진단
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1인 열람용)USD5,950 ⇒환산₩8,032,500견적의뢰/주문/질문
Multi User (5인 열람용)USD6,950 ⇒환산₩9,382,500견적의뢰/주문/질문
Global/corporate License (기업 열람용)USD8,950 ⇒환산₩12,082,500견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
글로벌 여성 건강 진단 시장의 성장과 동향
Grand View Research사의 최신 보고서에 따르면, 세계의 여성 건강 진단 시장 규모는 2030년까지 314억 달러에 달할 것으로 예상됩니다. 또한 2023년부터 2030년까지 연평균 7. 3%의 성장률을 보일 것으로 예상됩니다. 현장 진단의 도입 증가와 다양한 만성질환 및 생활습관병의 유병률 증가는 시장 성장을 촉진하는 주요 요인 중 하나입니다. 이 외에도 다양한 인식 개선 프로그램의 도입도 예측 기간 동안 시장에 유리하게 작용할 것으로 예상됩니다. 예를 들어, 2014년 유럽위원회는 '포괄적인 암 관리의 질 향상에 대한 유럽 가이드'의 공동 활동을 시작했습니다.

여성 건강 검진은 다양한 단체의 자금 지원 증가로 인해 높은 성장을 목격하고 있습니다. 예를 들어, 2015년 5월 Abcodia는 난소암 조기 발견을 위한 ROCA(Risk of Ovarian Cancer Algorithm) 검사를 영국에서 출시하기 위해 Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, UCLB로부터 800만 달러의 투자를 유치했습니다.

최종 용도별로는 병원/진단센터와 재택으로 나뉩니다. 병원 및 진단 센터는 병원 방문 횟수가 많고, 보다 확실한 검출이 가능하기 때문에 시장에서 큰 비중을 차지하고 있습니다.

아시아 태평양 지역 시장은 향후 몇 년 동안 크게 성장할 것으로 예상됩니다. 이 시장의 성장은 의료에 대한 투자 증가, 국제적인 장비 제조업체들이 이 지역의 판매망 강화에 주력하고 있으며, 지역 내 전염병에서 만성질환으로 역학이 전환되고 있기 때문입니다.

여성 건강 진단 시장 보고서 주요 내용

- 정부 및 민간단체의 투자 증가와 가처분 소득의 증가가 시장을 견인하고 있습니다.

- 2017년 시장 점유율은 암이 가장 높았습니다. 이 분야는 조기 발견 검사의 가용성과 암에 대한 정부의 노력으로 인해 예측 기간 동안 눈에 띄는 성장을 기록할 것으로 예상됩니다.

- 산전 검사는 산전 질환의 유병률 증가, 산모 연령 증가, 의료비 급증, 첨단 진단 검사 개발로 인해 같은 기간 동안 가장 빠르게 성장하는 분야로 추정됩니다.

- 지역별로는 북미가 2022년 44. 87%의 가장 큰 매출 점유율을 차지하며 시장을 주도할 것으로 보입니다. 진단센터 및 영상진단센터 기반 확대, 암 환자 증가, 불임 검사에 대한 인식 증가, 현장 검사 장비의 보급 등으로 인해 2025년까지 이 시장의 우위는 유지될 것으로 예상됩니다.
■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 시장 변동, 동향, 범위
Chapter 4. 세계의 여성 건강 진단 시장 : 용도별 예측 및 동향 분석
Chapter 5. 세계의 여성 건강 진단 시장 : 최종 용도별 예측 및 동향 분석
Chapter 6. 세계의 여성 건강 진단 시장 : 지역별 예측 및 동향 분석
Chapter 7. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. End-use
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Women’s Health Diagnostic Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Women’s Health Diagnostic Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies
Chapter 4. Women’s Health Diagnostic: Application Estimates & Trend Analysis
4.1. Women’s Health Diagnostic Market: Key Takeaways
4.2. Women’s Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Cancer
4.3.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Infectious diseases
4.4.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Osteoporosis
4.5.1. Osteoporosis market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Pregnancy & fertility
4.6.1. Pregnancy & fertility market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Prenatal
4.7.1. Prenatal market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Women’s Health Diagnostic: End-use Estimates & Trend Analysis
5.1. Women’s Health Diagnostic Market: Key Takeaways
5.2. Women’s Health Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Hospitals
5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Laboratory
5.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Homecare
5.5.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Women’s Health Diagnostic Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Women’s Health Diagnostic Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. F. Hoffmann-la Roche Ltd.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Siemens Aktiengeselischaft
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Quest Diagnostics incorporated
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Ge Healthcare
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Koninklijke Philips N.V.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Abbott Laboratories
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Becton, Dickinson and Company
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Hologic, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 3 North America women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 4 North America women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 8 Canada women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 10 Europe women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 11 Europe women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 12 Germany women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 13 Germany women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 14 UK women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 15 UK women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 16 France women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 17 France women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 18 Italy women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 19 Italy women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 20 Spain women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 21 Spain women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 22 Sweden women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 23 Sweden women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 24 Norway women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 25 Norway women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 26 Denmark women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 27 Denmark women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 29 Asia Pacific women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 31 China women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 32 China women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 33 Japan women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 34 Japan women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 35 India women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 36 India women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 37 Thailand women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 38 Thailand women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 39 South Korea women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 40 South Korea women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 41 Australia women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 42 Australia women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 43 Latin America women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 44 Latin America women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 45 Latin America women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 47 Brazil women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 48 Mexico women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 49 Mexico women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 50 Argentina women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 51 Argentina women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa women’s health diagnostic market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 56 South Africa women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 59 UAE women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 60 UAE women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)
Table 61 Kuwait women’s health diagnostic market, by application, 2018 - 2030 (USD Million)
Table 62 Kuwait women’s health diagnostic market, by end-use, 2018 - 2030 (USD Million)  
※본 조사보고서 [글로벌 여성 건강 진단 시장 (2023-2030) : 암, 전염병, 골다공증, 임신 및 출산, 산전] (코드 : GRV23NOV186) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [글로벌 여성 건강 진단 시장 (2023-2030) : 암, 전염병, 골다공증, 임신 및 출산, 산전] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!